INTRODUCTION
Eosinophilic granulomatosis with poliangiitis (EGPA; formerly known as Churg Strauss syndrome) is a systemic disorder characterised by asthma, peripheral eosinophilia, sinusitis and affection of different organic systems, e.g. peripheral nervous system, skin, kidney and gastrointestinal tract. EGPA is a rare entity that is characterised by widespread vasculitis which affects both small and medium -sized blood vessels, but in most cases initial clinical manifestations are asthma and skin changes (Sinico & Bottero 2009 ). The pathogenetic mechanisms are not completely clear. Following criteria are widely used for the EGPA diagnosis: asthma, eosinophilia (more than 10% in complete blood count -CBC), mono-or polyneuropathy, pulmonary infiltrates (may be transient), paranasal sinusitis and extra-vascular eosinophils (biopsy of arteries, arterioles or venules may demonstrate presence of eosinophilic infiltrates in the extravascular area) (Groh et al. 2015) . EGPA is a rare systemic disorder. The annual incidence varies according to the published literature, with estimated prevalence of 17.8/ 1.000.000 (Watts et al. 2005 ). The most common neurologic manifestation of EGPA are peripheral neuropathy, usually mononeuritis simplex which untreated, may progress to symmetric or asymmetric polyneuropathy. Central nervous system (CNS) involvement (cerebral infarction and haemorrhage) is rare (Wolf et al. 2010 ). Eosinophilic vasculitis affects central nervous system (CNS) in less than 10% of cases (Sinico & Bottero 2009 ). We present a case of a male patient with EGPA and depression that initially manifested with atypical and rare clinical presentation of recurrent transitory ischemic attacks (TIAs) with subsequent development of the ischemic stroke.
CASE REPORT
61-year-old patient with history of depression, arterial hypertension and chronic sinusitis presented with sudden onset weakness of the left extremities. After careful examination at emergency room patient was hospitalised in the neurology department. Complete regression of neurological deficit occurred an hour after the onset of neurological symptoms. On admission to the hospital, the patient has given his written informed consent for all necessary diagnostic procedures and treatment. Multi Slice Computed Tomography (MSCT) of the brain that was performed in emergency department prior to admission did not detect ischemic, haemorrhagic stroke nor intracranial mass lesions. Two weeks prior to the hospitalisation, patient had a similar attack of sudden left-sided weakness, which lasted approximately ten minutes, with complete recovery for reasons he did not seek medical assistance. Besides current neurological symptomatology, patient complained of fatigue, irritative cough, loss of appetite and weight loss, weakness in lower legs, feet and hand muscles with intermittently sub-febrile temperatures that started few months earlier. Because of these symptoms the patient was examined at a local hospital few months before, and aditional pulmonary evaluation was recommended, which was not done before the hospitalisation. Patient was examined by a psychiatrist and depressive episode was diagnosed and treatment with escitalopram started, which was gradually titrated up to 20 mg. Neurological examination revealed hoarseness, hypotrophy of the lower legs and feet with hypotrophy of the hand muscles (more prominent on the right), with diminished myotatic reflexes. Patient was mobile but had a wide -based gait and was incapable to stand on heel and toes. Laboratory testing found increased Creactive protein (CRP 88 mg/ L), erythrocyte sedimentation rate (ESR 36 mm/h), leukocytes (L 19.3 x 109/L), eosinophilia (57%), slight normocytic anaemia (Hemoglobin -Hb 115 g/L) and mild dyslipidaemia (Lowdensity lipoprotein -LDL -cholesterol 3.8 mmol/l). Coagulation tests were in normal value ranges.
Patient was initially treated with a acetylsalicylic acid (300 mg first day, then 100 mg per day) and atorvastatin (20 mg). Color Doppler Flow Imaging (CDFI) excluded significant stenosis of carotid arteries. Echocardiography demonstrated normal systolic function without enlargement of the ventricles and valvular system without significant dysfunction. 24-hour Holter electrocardiogam showed stabile sinus rhythm, without significant ventricular ectopic activity and paroxysmal atrial fibrillation. On the third day of hospitalisation, left-sided weakness occurred again with left-sided supranuclear lesion of the facial nerve that persisted throughout the duration of the hospitalisation. We report a case of 61-year-old male patient with history of depression who presented with two TIAs and subsequent development of the ischemic stroke in the region of the MCA. Even though patient had risk factors for the cerebrovascular disorders (arterial hypertension and mild dyslipidaemia), we made a diagnosis of EGPA based on a clinical and laboratory signs that included chronic sinusitis, eosinophilia, polyneuropathy and asthma, as well as presence of p-ANCAs. Furthermore, depression significantly increased the risk and develoment of stroke and this increase is probably independent of other risk factors (Dong et. al. 2012 ). In the published literature, we found several cases of EGPA where patients suffered from a cardioembolic stroke (Cheng et In published literature we did not find reports of EGPA and TIA. EGPA is the rarest of the antineutrophilic cytoplasmic antibody vasculitides. In this case, occurrence of TIA in our patient, was the first, severe symptoms and initial manifestation of EGPA and reason for hospitalisation.
CONCLUSION
Although, patient had a history of chronic sinusitis, weight loss, subfebrility, fatigue, chronic cough, paraesthesia and muscle pain, recurrent TIAs with subsequent development of the ischemic stroke were the initial, important manifestation that resulted in the hospitalisation and detailed diagnostic procedures. We would like to emphasise, that when managing patients with TIAs or stroke, besides more common risk factors such as atherothrombosis or thromboembolism as a result of atrial fibrillation, it is also important to consider other, rare causes that may require specific treatment.
